Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cellulose sulfate - Polydex Pharmaceuticals/CONRAD

Drug Profile

Cellulose sulfate - Polydex Pharmaceuticals/CONRAD

Alternative Names: Ushercell

Latest Information Update: 03 Feb 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Polydex Pharmaceuticals
  • Developer CONRAD
  • Class Antivirals; Biopolymers; Contraceptives; Glucans
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Suspended Bacterial vaginosis; Pregnancy
  • Discontinued Chlamydial infections; Gonorrhoea; HIV infections

Most Recent Events

  • 31 Jul 2012 Cellulose sulfate - Polydex Pharmaceuticals/CONRAD is available for licensing as of 31 Jul 2012. http://www.polydex.com/
  • 31 Dec 2010 Suspended - Clinical-Phase-Unknown for Pregnancy (Prevention) in Zimbabwe (Vaginal)
  • 31 Dec 2010 Suspended - Phase-I for Pregnancy (Prevention) in Dominican Republic (Vaginal)
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top